Amaero International has completed an institutional placement to raise approximately AUD 22 million, securing support from existing cornerstone investors and introducing a new US-based institutional investor.
The placement, priced at A$0.30 per share—representing a 10.4 per cent discount to the last closing price—was fully subscribed by Pegasus Growth Capital, the Amaero Board, four lead institutional investors, and a new institutional participant from the United States.
As a result of the capital raise, Regal Funds Management and IFM Investors will join Pegasus Growth Capital and Fidelity International as substantial investors in the company.
Amaero Chairman and CEO Hank Holland highlighted the significance of the capital raising, emphasising its role in securing the company’s transition to commercialisation in FY2026.
“As we transition to commercialisation in FY2026, this equity capital raise concludes a series of strategic capital raises since May 2022 that have totalled approximately A$100 million,” Holland said.
“This financing satisfies the precedent condition in the recently announced EXIM Bank loan to complete capital raise prior to first loan draw and it fully funds the planned capital expenditures and operations through anticipated EBITDA breakeven in FY2026.”
The company now holds a post-transaction pro forma cash balance of approximately A$41.5 million, bolstered by a recent A$37.8 million loan from the Export-Import Bank of the United States.
According to Amaero, these funds position the company on firm financial footing as it progresses toward large-scale production.
Holland underscored Amaero’s strategic focus on strengthening the United States’ supply chain resilience.
“With the support of our stakeholders, we continue to focus on our strategic positioning as the largest capacity and most responsive U.S. domestic producer of C103, refractory, and specialty AM powders for additive manufacturing,” he stated.
“We have taken bold and deliberate action to address critical gaps in the United States’ supply chain and to create a more resilient and more scalable domestic manufacturing capability for mission-critical defence, space, and aerospace applications.”
The placement will see the issuance of approximately 73.3 million new fully paid ordinary shares to eligible sophisticated, professional, and institutional investors.
Upon completion, the newly issued shares will represent 11.9% of Amaero’s existing issued capital.
Curran & Co acted as the sole lead manager and bookrunner for the placement, while Gilbert + Tobin served as the company’s Australian legal advisor.
